Savient Pharmaceuticals Inc Com (NASDAQOTH:SVNTQ)

CAPS Rating: 2 out of 5

A biopharmaceutical company engaged in developing and distributing pharmaceutical products that target unmet medical needs in both niche and broader markets.

Recs

1
Player Avatar justaboutperfect (< 20) Submitted: 10/14/2011 12:31:21 PM : Outperform Start Price: $3.74 SVNTQ Score: -114.60

This one has better potential of going up and less risk of going down in long term from this point on. Co will be bought out at a price more than what it is trading at now.

Featured Broker Partners


Advertisement